INTRODUCTION
Cutaneous biphasic sarcomatoid carcinoma is a rare malignancy that shows both an epithelial and a mesenchymal component. The epithelial component may include basal cell carcinoma, squamous cell carcinoma, and malignant adnexal tumor, whereas the mesenchymal component may comprise poorly differentiated spindle cells, along with heterologous elements, such as chondroblastic and osteoblastic differentiation [1] [2] [3] . To the best of our knowledge, this is the sixth report of sarcomatoid eccrine porocarcinoma (SEP) in the skin [2] [3] [4] and the first report of collision tumor associated with SEP and basal cell carcinoma. We present a case of a 57-year-old male patient with characteristic features of SEP, combined with basal cell carcinoma, which was successfully managed through performing a wide local excision and a split-thickness skin graft.
CASE REPORT
A 57-year-old male presented at our hospital with an ulcerated, beefy red nodule, with adjacent pinhead to bean-sized multiple nevi in the right zygoma (Fig. 1A) . The pruritic, erythematous lesion had been present for a long time and the lesion was reported to have rapidly increased in size over the previous four weeks, prior to the hospital visit. Further examination revealed an ill-defined, rice grain-sized, eroding deep brown patch in the superior portion of the nasal bridge, between the eyes (Fig. 1B) .
The patient worked as a street vendor, and a history of high skin-sun exposure was noted. Clinically, the lesion in the zygoma was suspected to be a squamous cell carcinoma and the lesion between the eyes suspected to be a basal cell carcinoma. Local biopsy, with provisional diagnosis and subsequent wide local excision and split-thickness skin graft, was performed. In the right zygoma, a relatively well circumscribed hypercellular tumor, which occupied the dermis down to the subcutaneous fat layer, with surface ulceration was seen ( Fig. 2A) . There was no benign eccrine poromatous lesions. Glandular architecture similar to eccrine glands was merged with poorly differentiated, Fig. 3D ) and epithelial membrane antigen (EMA) (Fig. 3E) were positive in gland forming cells, which were negative for vimentin. Ductal cells are highlighted by special stain periodic acid-Schiff (PAS)/diastase-resistant PAS (Fig. 3F ). Basaloid cells expressed cytokeratin and p63, and were negative for vimentin and CEA. The study was approved by the Institutional Review Board of the Inje University Busan Paik Hospital (IRB no. 17-0029). We received the patient's consent form about publishing all photographic materials.
DISCUSSION
Eccrine porocarcinomas (EP) may arise de novo or resulting from a malignant transformation of long-standing benign counterparts including poroma, hydroacanthoma simplex, or in association with sebaceous nevi 1 3 reported two cases of sarcomatoid carcinomas, which were undifferentiated, with pseudo-angiosarcomatous change to the morphologic spectrum of eccrine porocarcinoma. In one of them, the tumor was composed predominantly of compact fascicles of malignant spindle cells and of focal malignant ductal differentiation. They coined the term 'sarcomatoid eccrine porocarcinoma' (SEP). It is an extremely rare tumor, and to the best of our knowledge, this is the sixth report of SEP in the skin 2-4 .
SEP is a sweat gland tumor, which is characterized by predominant spindle cells with ductal differentiation. Unfortunately, when the tumor is poorly differentiated, malignant tumors may not show obvious duct formation and that makes it difficult to distinguish SEP from spindle cell squamous cell carcinoma or carcinosarcoma. However, spindle cell squamous cell carcinomas are commonly composed entirely of pleomorphic spindle cells without epidermal components or squamous differentiation. Furthermore, actinic keratosis, or an epithelial-to-spindle cell transitional area, or an intercellular bridge could be helpful to distinguish them from SEPs. Identifying the glandular components among the spindle cell lesion is the most important factor in diagnosing SEP. Sometimes using immunohistochemical markers can be helpful to confirm diagnosis with a high index of certainty. Owing to the biphasic nature of both epithelial and mesenchymal components, it is necessary to differentiate SEPs from carcinosarcomas, which are frequently reported in the female genital tract among diverse anatomical sites. Kwan and Satter 5 reported that primary cutaneous carcinosarcoma has both malignant mesenchymal and epithelial components, in varying proportions, with no transition between them. Unlike spindle cells that show strongly positive reactions for cytokeratin and vimentin in SEP, carcinosarcoma usually shows distinctive patterns that display cytokeratin-positive epithelial components and vimentinpositive mesenchymal components. Strictly, SEP is not in the spectrum of carcinosarcomas. However, there are some differences of view among authors concerning the concept of primary cutaneous carcinosarcoma 3, [6] [7] [8] focused on the outstanding features of well-formed ducts and insisted that to confirm SEP, it is crucial to recognize the glandular structure in the sarcomatous components. However, in poorly differentiated EPs, malignant tumors may not show obvious duct formation in routine hematoxylin and eosin slides. Sometimes, performing electron microscopy and immunohistochemistry may help in finding ducts or intracytoplasmic lumina 10 . In our case, the duct-like lesion was positive for EMA and CEA, which provides further evidence of a possible eccrine gland origin.
In the most recent report of SEP, Le et al. 11 used the term 'biphasic sarcomatoid porocarcinoma', in which they described epithelial malignancies, with a spindle-cell component demonstrating some mesenchymal markers. On the other hand, monophasic sarcomatoid carcinomas were pure spindle cell tumors expressing markers of both epithelial and mesenchymal tumors. Either a monophasic or a biphasic sarcomatoid carcinoma diagnosis could be applied in our case, causing confusion through the presence of both epithelial and mesenchymal markers evident. To classify SEP from among these continuously emerging medical terms, we should prioritize through a focus on characteristic histopathologic findings, additional support from immunohistochemical staining, and consideration of previous references. Finally, we should consider the clinical impressions of dermatologists, because SEPs can be found in basal cell carcinoma, squamous cell carcinoma, and nevoid lesion settings. Although SEP is uncommon, it is important for pathologists to be aware of this disease entity, which has aggressive characteristic features including a high recurrence rate, frequent lympho-vascular invasion, peri-neural invasion, and very poor prognosis. Total removal of the tumor and close follow-up is necessary.
